BioNTech SE BNTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
112.33quote price arrow down-1.84 (-1.61%)
Volume
1,106,651
52 week range
28.00 - 131.00

...

Loading . . .

KEY STATS

  • Open114.87
  • Day High117.35
  • Day Low111.18
  • Prev Close112.33
  • 52 Week High131.00
  • 52 Week High Date12/11/20
  • 52 Week Low28.00
  • 52 Week Low Date03/12/20
  • Market Cap27.048B
  • Shares Out240.79M
  • 10 Day Average Volume1.47M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change235.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.01
  • P/E (TTM)-55.98
  • Fwd P/E (NTM)11.80
  • EBITDA (MRQ)-103.165M
  • ROE (MRQ)-
  • Revenue (MRQ)161.56M
  • Gross Margin (MRQ)88.28%
  • Net Margin (MRQ)-85.07%
  • Debt To Equity (MRQ)33.50%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany